Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population

Journal of Clinical Gastroenterology

Volumn 42, Issue 10, 2008, Pages 1074-1079

  Tseng, Ping Huei ^a   Lee, Yi Chia ^b,c   Chiu, Han Mo ^c   Huang, Shih Pei ^c   Liao, Wei Chih ^c   Chen, Chien Chuan ^c   Wang, Hsiu Po ^d   Wu, Ming Shiang ^c   Lin, Jaw Town ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Institute of Occupational Medicine and Industrial Hygiene   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Barrett esophagus; Endoscopically suspected esophageal metaplasia; Endoscopy; Erosive esophagitis; Hiatal hernia

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BARRETT ESOPHAGUS; CHINESE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INTESTINE BIOPSY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SMOKING; CHINA; ESOPHAGUS TUMOR; HEALTH SURVEY; HIATUS HERNIA; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CHINA; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; HERNIA, HIATAL; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 57049106145     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31809e7126     Document Type: Article

References (45)

1. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976;295:476-480.
2. Winters C Jr, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92:118-124.
3. Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarci-noma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology. 2002;122:588-590.
4. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarci-noma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999;94: 2037-2042.
5. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992;103:1241-1245.
6. Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophago-gastric junction: prevalence and clinical data. Gastroenterology. 1999;116:277-285.
7. Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA. 2002; 287:1972-1981.
8. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology. 2002;123:461-467.
9. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831.
10. Kim JY, Kim YS, Jung MK, et al. Prevalence of Barrett's esophagus in Korea. J Gastroenterol Hepatol. 2005;20:633-636.
11. Lee JI, Park H, Jung HY, et al. Prevalence of Barrett's esophagus in an urban Korean population: a multicenter study. J Gastroenterol. 2003;38:23-27.
12. Tatsuyuki Kawano KO, Nakajima Y, Nishikage T, et al. Prevalence of Barrett's esophagus in Japan. Esophagus. 2006;3:155-164.
13. Wong WM, Lam SK, Hui WM, et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese - prevalence and spectrum of the disease. Aliment Pharmacol Ther. 2002;16: 2037-2042.
14. Yeh C, Hsu CT, Ho AS, et al. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci. 1997;42:702-706.
15. Zhang J, Chen XL, Wang KM, et al. Barrett's esophagus and its correlation with gastroesophageal reflux in Chinese. World J Gastroenterol. 2004;10:1065-1068.
16. Endlicher E, Rummele P, Beer S, et al. Barrett's esophagus: a discrepancy between macroscopic and histological diagnosis. Endoscopy. 2005;37:1131-1135.
17. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-1120; quiz 1943.
18. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press; 2004.
19. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172-180.
20. Amano Y, Kushiyama Y, Yuki T, et al. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol. 2006;41:873-879.
21. Gadour MO, Ayoola EA. Barrett's oesophagus and oesophageal cancer in Saudi Arabia. Trop Gastroenterol. 1999;20:111-115.
22. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci. 2004;49:237-242.
23. Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004;16:495-501.
24. Yilmaz N, Tuncer K, Tuncyurek M, et al. The prevalence of Barrett's esophagus and erosive esophagitis in a tertiary referral center in Turkey. Turk J Gastroenterol. 2006;17:79-83.
25. Lee YC, Wang HP, Chiu HM, et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroeso-phageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol. 2006;21:798-804.
26. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670-1677.
27. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344: 1533-1536.
28. Johnston MH, Hammond AS, Laskin W, et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol. 1996;91:1507-1511.
29. Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61:226-231.
30. Ward EM, Wolfsen HC, Achem SR, et al. Barrett's esophagus is common in older men and women undergoing screening colono-scopy regardless of reflux symptoms. Am J Gastroenterol. 2006; 101:12-17.
31. Blustein PK, Beck PL, Meddings JB, et al. The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol. 1998;93:2508-2512.
32. Veldhuyzen van Zanten SJ, Thomson AB, Barkun AN, et al. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment Pharmacol Ther. 2006;23: 595-599.
33. Pena Alfaro NG, Manrique MA, Chavez Garcia MA, et al. Prevalence of Barrett's esophagus in non-selected patients submitted to esophagogastroduodenoscopy and associated risk factors. Rev Gastroenterol Mex. 2005;70:20-24.
34. Csendes A, Smok G, Burdiles P, et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastro-esophageal reflux. Dis Esophagus. 2003;16:24-28.
35. de Mas CR, Kramer M, Seifert E, et al. Short Barrett: prevalence and risk factors. Scand J Gastroenterol. 1999;34:1065-1070.
36. Mantynen T, Farkkila M, Kunnamo I, et al. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol. 2002; 97:2524-2529.
37. Toruner M, Soykan I, Ensari A, et al. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol. 2004;19:535-540.
38. Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am J Gastroenterol. 2006;101:1178-1182.
39. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199-211.
40. Stein DJ, El-Serag HB, Kuczynski J, et al. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther. 2005;22:1005-1010.
41. El-Serag HB, Kvapil P, Hacken-Bitar J, et al. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005;100: 2151-2156.
42. Caygill CP, Johnston DA, Lopez M, et al. Lifestyle factors and Barrett's esophagus. Am J Gastroenterol. 2002;97:1328-1331.
43. Veugelers PJ, Porter GA, Guernsey DL, et al. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus. 2006;19:321-328.
44. Bu X, Ma Y, Der R, et al. Body mass index is associated with Barrett esophagus and cardiac mucosal metaplasia. Dig Dis Sci. 2006;51:1589-1594.
45. Gudlaugsdottir S, Verschuren W, Dees J, et al. Hypertension is frequently present in patients with reflux esophagitis or Barrett's esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med. 2002;13:369.